Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long-term Follow-up Study in Participants Who Received CS-101
Sponsor: CorrectSequence Therapeutics Co., Ltd
Summary
This is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-06 (NCT06024876),No investigational drug product will be administered in the study.
Official title: A Long-term Follow-up Study Evaluating the Safety and Efficacy of Subjects With β-thalassemia Treated With Base-edited Autologous Hematopoietic Stem Cell (CS-101) Transplantation
Key Details
Gender
All
Age Range
6 Years - 35 Years
Study Type
OBSERVATIONAL
Enrollment
5
Start Date
2025-01-18
Completion Date
2039-07
Last Updated
2026-02-10
Healthy Volunteers
No
Conditions
Interventions
Safety and efficacy assessments
Safety evaluations,disease-specific assessments,and assessments to monitor for long-term complications of autologous transplant
Locations (1)
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China